Peptide-bound glycative, AGE and oxidative modifications as biomarkers for the diagnosis of Alzheimer’s disease: a feasibility study
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
19 September 2024
|
| In: |
Biomedicines
Year: 2024, Jahrgang: 12, Heft: 9, Pages: 1-17 |
| ISSN: | 2227-9059 |
| DOI: | 10.3390/biomedicines12092127 |
| Online-Zugang: | Resolving-System, kostenfrei: https://doi.org/10.3390/biomedicines12092127 Resolving-System, kostenfrei: https://doi.org/10.25673/117023 
|
| Verfasserangaben: | by Anne Grosskopf, Jette Rahn, Ahyoung Kim, Gábor Szabó, Frank Klawonn, Andrej Frolov and Andreas Simm |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1905971737 | ||
| 003 | DE-627 | ||
| 005 | 20260205093125.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 241017s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/biomedicines12092127 |2 doi | |
| 024 | 7 | |a 10.25673/117023 |2 doi | |
| 035 | |a (DE-627)1905971737 | ||
| 035 | |a (DE-599)KXP1905971737 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Grosskopf, Anne |e VerfasserIn |4 aut | |
| 245 | 1 | 0 | |a Peptide-bound glycative, AGE and oxidative modifications as biomarkers for the diagnosis of Alzheimer’s disease |b a feasibility study |c by Anne Grosskopf, Jette Rahn, Ahyoung Kim, Gábor Szabó, Frank Klawonn, Andrej Frolov and Andreas Simm |
| 264 | 1 | |c 19 September 2024 | |
| 300 | |b Diagramm | ||
| 300 | |a 17 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 540 | |q DE-3 |a Namensnennung 4.0 International |f CC BY 4.0 |2 cc |u https://creativecommons.org/licenses/by/4.0/ | ||
| 700 | 1 | |a Rahn, Jette |d 1988- |e VerfasserIn |0 (DE-588)1206131055 |0 (DE-627)1691919047 |4 aut | |
| 700 | 1 | |a Kim, Ahyoung |e VerfasserIn |4 aut | |
| 700 | 1 | |a Szabó, Gábor |d 1969- |e VerfasserIn |0 (DE-588)1022955152 |0 (DE-627)717338681 |0 (DE-576)366215485 |4 aut | |
| 700 | 1 | |a Klawonn, Frank |d 1964- |e VerfasserIn |0 (DE-588)113214030 |0 (DE-627)502583207 |0 (DE-576)170210472 |4 aut | |
| 700 | 1 | |a Frolov, Andrej |d 1975- |e VerfasserIn |0 (DE-588)137568908 |0 (DE-627)695866796 |0 (DE-576)303483288 |4 aut | |
| 700 | 1 | |a Simm, Andreas |e VerfasserIn |0 (DE-588)1249116376 |0 (DE-627)1785363719 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Biomedicines |d Basel : MDPI, 2013 |g 12(2024), 9, Artikel-ID 2127, Seite 1-17 |h Online-Ressource |w (DE-627)750370483 |w (DE-600)2720867-9 |w (DE-576)384589596 |x 2227-9059 |7 nnas |a Peptide-bound glycative, AGE and oxidative modifications as biomarkers for the diagnosis of Alzheimer’s disease a feasibility study |
| 773 | 1 | 8 | |g volume:12 |g year:2024 |g number:9 |g elocationid:2127 |g pages:1-17 |g extent:17 |a Peptide-bound glycative, AGE and oxidative modifications as biomarkers for the diagnosis of Alzheimer’s disease a feasibility study |
| 856 | 4 | 0 | |u https://doi.org/10.3390/biomedicines12092127 |x Resolving-System |z kostenfrei |7 0 |
| 856 | 4 | 0 | |u https://doi.org/10.25673/117023 |x Resolving-System |z kostenfrei |7 0 |
| 951 | |a AR | ||
| 992 | |a 20260205 | ||
| 993 | |a Article | ||
| 994 | |a 2024 | ||
| 998 | |g 1022955152 |a Szabó, Gábor |m 1022955152:Szabó, Gábor |d 910000 |d 910200 |d 50000 |e 910000PS1022955152 |e 910200PS1022955152 |e 50000PS1022955152 |k 0/910000/ |k 1/910000/910200/ |k 0/50000/ |p 4 | ||
| 999 | |a KXP-PPN1905971737 |e 4876877378 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"title":"Peptide-bound glycative, AGE and oxidative modifications as biomarkers for the diagnosis of Alzheimer’s disease","title_sort":"Peptide-bound glycative, AGE and oxidative modifications as biomarkers for the diagnosis of Alzheimer’s disease","subtitle":"a feasibility study"}],"id":{"eki":["1905971737"],"doi":["10.3390/biomedicines12092127","10.25673/117023"]},"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"display":"Grosskopf, Anne","given":"Anne","role":"aut","family":"Grosskopf"},{"family":"Rahn","given":"Jette","role":"aut","display":"Rahn, Jette"},{"display":"Kim, Ahyoung","role":"aut","given":"Ahyoung","family":"Kim"},{"family":"Szabó","role":"aut","given":"Gábor","display":"Szabó, Gábor"},{"display":"Klawonn, Frank","given":"Frank","role":"aut","family":"Klawonn"},{"given":"Andrej","role":"aut","family":"Frolov","display":"Frolov, Andrej"},{"display":"Simm, Andreas","family":"Simm","given":"Andreas","role":"aut"}],"relHost":[{"origin":[{"dateIssuedKey":"2013","dateIssuedDisp":"2013-","publisherPlace":"Basel","publisher":"MDPI"}],"pubHistory":["1.2013 -"],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 12.08.20"],"id":{"zdb":["2720867-9"],"issn":["2227-9059"],"eki":["750370483"]},"part":{"volume":"12","year":"2024","issue":"9","extent":"17","text":"12(2024), 9, Artikel-ID 2127, Seite 1-17","pages":"1-17"},"title":[{"title_sort":"Biomedicines","title":"Biomedicines","subtitle":"open access journal"}],"physDesc":[{"extent":"Online-Ressource"}],"recId":"750370483","disp":"Peptide-bound glycative, AGE and oxidative modifications as biomarkers for the diagnosis of Alzheimer’s disease a feasibility studyBiomedicines"}],"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"19 September 2024"}],"name":{"displayForm":["by Anne Grosskopf, Jette Rahn, Ahyoung Kim, Gábor Szabó, Frank Klawonn, Andrej Frolov and Andreas Simm"]},"recId":"1905971737","physDesc":[{"extent":"17 S.","noteIll":"Diagramm"}]} | ||
| SRT | |a GROSSKOPFAPEPTIDEBOU1920 | ||